ALPS Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Sell |
74,550
-28,278
| -28% | -$143K | ﹤0.01% | 823 |
|
|
2025
Q1 | $666K | Sell |
102,828
-8,532
| -8% | -$55.3K | ﹤0.01% | 554 |
|
|
2024
Q4 | $817K | Buy |
+111,360
| New | +$817K | 0.01% | 535 |
|
|
2024
Q2 | – | Sell |
-95,242
| Closed | -$965K | – | 1005 |
|
|
2024
Q1 | $965K | Buy |
95,242
+3,124
| +3% | +$31.6K | 0.01% | 493 |
|
|
2023
Q4 | $927K | Sell |
92,118
-7,001
| -7% | -$70.4K | 0.01% | 500 |
|
|
2023
Q3 | $929K | Buy |
99,119
+641
| +0.7% | +$6.01K | 0.01% | 482 |
|
|
2023
Q2 | $2.42M | Buy |
98,478
+10,505
| +12% | +$258K | 0.02% | 276 |
|
|
2023
Q1 | $2.05M | Sell |
87,973
-2,239
| -2% | -$52.1K | 0.02% | 284 |
|
|
2022
Q4 | $2.28M | Buy |
90,212
+17,794
| +25% | +$450K | 0.02% | 277 |
|
|
2022
Q3 | $1.4M | Sell |
72,418
-21,126
| -23% | -$407K | 0.01% | 372 |
|
|
2022
Q2 | $2.38M | Buy |
93,544
+78,374
| +517% | +$2M | 0.02% | 284 |
|
|
2022
Q1 | $390K | Buy |
+15,170
| New | +$390K | ﹤0.01% | 496 |
|
|
2021
Q4 | – | Sell |
-160,089
| Closed | -$6.97M | – | 981 |
|
|
2021
Q3 | $6.97M | Sell |
160,089
-10,690
| -6% | -$465K | 0.07% | 162 |
|
|
2021
Q2 | $8.07M | Sell |
170,779
-35,637
| -17% | -$1.68M | 0.07% | 152 |
|
|
2021
Q1 | $10.6M | Sell |
206,416
-23,236
| -10% | -$1.19M | 0.1% | 143 |
|
|
2020
Q4 | $6.15M | Buy |
229,652
+67,623
| +42% | +$1.81M | 0.07% | 164 |
|
|
2020
Q3 | $5.56M | Buy |
162,029
+1,202
| +0.7% | +$41.3K | 0.08% | 152 |
|
|
2020
Q2 | $6.59M | Buy |
+160,827
| New | +$6.59M | 0.09% | 140 |
|